Novartis Financial Results – Q1 2024
Novartis announced the company’s financial results for the first quarter of 2024.
Novartis in Society Integrated Report 2023
This report covers our business, strategy, and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.
About Us
At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives.
Drug delivery, service delivery, and the future of cancer care
State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.
Beacon of Hope
Novartis is expanding the Beacon of Hope program through new collaborations to address systemic health disparities.
